- Home
- CRBP vs AGAE Comparison
CRBP vs AGAE Comparison
Compare CRBP & AGAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBP
- AGAE
- Stock Information
- Founded
- CRBP 2009
- AGAE 2017
- Country
- CRBP United States
- AGAE United States
- Employees
- CRBP N/A
- AGAE N/A
- Industry
- CRBP Biotechnology: Pharmaceutical Preparations
- AGAE Cable & Other Pay Television Services
- Sector
- CRBP Health Care
- AGAE Telecommunications
- Exchange
- CRBP Nasdaq
- AGAE Nasdaq
- Market Cap
- CRBP 73.4M
- AGAE 84.7M
- IPO Year
- CRBP N/A
- AGAE N/A
- Fundamental
- Price
- CRBP $7.34
- AGAE $2.59
- Analyst Decision
- CRBP Strong Buy
- AGAE
- Analyst Count
- CRBP 10
- AGAE 0
- Target Price
- CRBP $53.56
- AGAE N/A
- AVG Volume (30 Days)
- CRBP 114.6K
- AGAE 606.3K
- Earning Date
- CRBP 05-06-2025
- AGAE 06-13-2025
- Dividend Yield
- CRBP N/A
- AGAE N/A
- EPS Growth
- CRBP N/A
- AGAE N/A
- EPS
- CRBP N/A
- AGAE N/A
- Revenue
- CRBP N/A
- AGAE $9,256,023.00
- Revenue This Year
- CRBP N/A
- AGAE N/A
- Revenue Next Year
- CRBP $150.00
- AGAE N/A
- P/E Ratio
- CRBP N/A
- AGAE N/A
- Revenue Growth
- CRBP N/A
- AGAE 36.15
- 52 Week Low
- CRBP $4.64
- AGAE $0.66
- 52 Week High
- CRBP $61.90
- AGAE $3.79
- Technical
- Relative Strength Index (RSI)
- CRBP 52.51
- AGAE 60.80
- Support Level
- CRBP $7.05
- AGAE $1.77
- Resistance Level
- CRBP $7.62
- AGAE $3.79
- Average True Range (ATR)
- CRBP 0.49
- AGAE 0.45
- MACD
- CRBP -0.02
- AGAE 0.09
- Stochastic Oscillator
- CRBP 42.65
- AGAE 46.67
About CRBP Corbus Pharmaceuticals Holdings Inc.
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
About AGAE Allied Gaming & Entertainment Inc.
Allied Gaming & Entertainment Inc is an experiential entertainment company focused on providing a growing world of gamers with various experiences through renowned assets, products, and services.